Literature DB >> 9429218

In vitro characterization of lectin-induced alterations on the proliferative activity of three human melanoma cell lines.

P Loréa1, D Goldschmidt, F Darro, I Salmon, N Bovin, H J Gabius, R Kiss, A Danguy.   

Abstract

Lectin binding is known to be able to elicit signalling events relevant for various aspects of cell physiology. The influence of lectin binding on melanoma cells remains relatively unexplored. The aim of our study was to investigate the in vitro effects of five plant lectins, namely peanut (PNA), wheat germ (WGA), concanavalin A (Con-A), Griffonia simplicifolia (GSA-IA4) and Phaseolus vulgaris (PHA-L) agglutinins, on the cell proliferation of melanoma cell lines (SK-MEL-28, HT-144 and C32) cultured in media supplemented with either 10% or 1% fetal calf serum (FCS). Cell proliferation was assessed by means of the tetrazolium derivative reduction (MTT) assay. Four lectin concentrations were tested, namely 0.05, 0.5, 5 and 50 micrograms/ml, in four experimental settings, namely 1, 3, 5 and 7 days after the addition of each lectin to the culture media. Determination of the cell gain compartment (percentage of cells in the S and G2 phases of the cell cycle) was done by means of digital cell image analysis assessed on Feulgen-stained nuclei. Our results demonstrated that of the five lectins under study, four had a globally significant dose-dependent toxic effect on melanoma cell proliferation. The fifth lectin, PNA, had a significant stimulatory effect on the C32 cell line. Low doses of lectins may produce a transient increase in cell proliferation. Increasing the FCS from 1% to 10% in the culture media significantly antagonized lectin-induced toxicity in the three cell lines. The cell kinetics measurements showed that the inhibition of cell growth was merely due to cell death. The present data strongly suggest that some lectins might influence the proliferation of melanoma cells. In addition, because lectins are present in our diet and are able to pass into the systemic circulation, we speculate that lectins may exert an influence on melanoma growth under clinical conditions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9429218     DOI: 10.1097/00008390-199710000-00001

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  7 in total

1.  3'-Azidothymidine significantly alters glycosphingolipid synthesis in melanoma cells and decreases the shedding of gangliosides.

Authors:  R Steet; M Alizadeh; P Melançon; R D Kuchta
Journal:  Glycoconj J       Date:  1999-03       Impact factor: 2.916

2.  Direct targeting of cancer cells: a multiparameter approach.

Authors:  Eileen L Heinrich; Lily Anne Y Welty; Lisa R Banner; Steven B Oppenheimer
Journal:  Acta Histochem       Date:  2005-09-21       Impact factor: 2.479

3.  Analysis of unconventional approaches for the rapid detection of surface lectin binding ligands on human cell lines.

Authors:  Lily Anne Y Welty; Eileen L Heinrich; Karina Garcia; Lisa R Banner; Michael L Summers; Larry Baresi; Stan Metzenberg; Cathy Coyle-Thompson; Steven B Oppenheimer
Journal:  Acta Histochem       Date:  2006-01-18       Impact factor: 2.479

4.  Lectin binding and effects in culture on human cancer and non-cancer cell lines: examination of issues of interest in drug design strategies.

Authors:  Karineh Petrossian; Lisa R Banner; Steven B Oppenheimer
Journal:  Acta Histochem       Date:  2007-08-16       Impact factor: 2.479

Review 5.  Plant Lectins Targeting O-Glycans at the Cell Surface as Tools for Cancer Diagnosis, Prognosis and Therapy.

Authors:  Guillaume Poiroux; Annick Barre; Els J M van Damme; Hervé Benoist; Pierre Rougé
Journal:  Int J Mol Sci       Date:  2017-06-09       Impact factor: 5.923

6.  Wheat Germ Agglutinin as a Potential Therapeutic Agent for Leukemia.

Authors:  Bradley Ryva; Keman Zhang; Abhishek Asthana; Derek Wong; Yorleny Vicioso; Reshmi Parameswaran
Journal:  Front Oncol       Date:  2019-02-21       Impact factor: 6.244

7.  Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta.

Authors:  Janina Auth; Maria Fröba; Maximilian Große; Pia Rauch; Natalia Ruetalo; Michael Schindler; Martina Morokutti-Kurz; Philipp Graf; Andrea Dolischka; Eva Prieschl-Grassauer; Christian Setz; Ulrich Schubert
Journal:  Int J Mol Sci       Date:  2021-09-22       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.